This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_COLON_EXALLC for full statistics.
Malignant neoplasm of colon
C3_COLON
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5940 |
4. Check minimum number of eventsNone |
5940 |
5. Include endpointsNone |
5940 |
6. Filter based on genotype QC (FinnGen only) |
5940 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of colon
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5940 | 2670 | 3270 |
| Unadjusted period prevalence (%) | 1.20 | 0.91 | 1.44 |
| Median age at first event (years) | 69.24 | 67.83 | 70.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5491
- Matched controls
- 54909
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JN4AD
NOMESCO Finland
Body CT examination
5.8
323.0
1094
2272
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.6
323.0
888
982
JFB30
NOMESCO Finland
Right hemicolectomy
112.6
323.0
1177
133
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
372.0
323.0
735
23
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
2123.4
323.0
543
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
16384.0
323.0
1427
*
JN4BD
NOMESCO Finland
Extensive body CT
7.4
323.0
1884
3627
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
323.0
683
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
5.6
323.0
1201
2603
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
629.1
323.0
900
17
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
201.0
323.0
1017
62
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
285.7
323.0
1421
67
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.8
323.0
1163
1222
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
565.1
323.0
1021
22
UJF32
NOMESCO Finland
Coloscopy
9.3
323.0
3658
9707
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
1943.7
323.0
347
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
204.0
323.0
380
20
B01AB05
ATC
enoxaparin; parenteral
4.0
323.0
2896
12029
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
4308.2
323.0
768
*
H02AB02
ATC
dexamethasone; systemic
5.7
323.0
1373
3042
L01BC06
ATC
capecitabine; oral
46.6
323.0
1884
609
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
150.0
323.0
1104
92
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
542.2
323.0
404
8
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
1825.6
323.0
330
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.7
323.0
2477
6906
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
9.4
323.0
737
887
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
30.9
323.0
682
251
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
448.6
323.0
456
11
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
16.2
323.0
677
471
130
Kela drug reimbursment
Malignant tumour
16.6
323.0
2532
2693
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
245.1
323.0
761
36
A04AA02
ATC
granisetron; systemic, transdermal
10.9
323.0
1236
1422
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
15.6
323.0
573
408
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
15.6
319.3
543
384
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
149.0
317.7
336
24
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
472.9
317.0
314
7
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
201.1
311.5
322
17
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
1603.0
307.9
297
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.1
298.8
891
1681
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
738.3
287.2
281
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
285.4
2147
9447
JFB46
NOMESCO Finland
Resection of sigmoid colon
19.9
284.7
440
239
WZC30
NOMESCO Finland
Teaching
3.9
270.9
1320
4133
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
464.9
269.1
267
6
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
+∞
269.0
256
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.1
264.3
1188
3452
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
23.0
264.3
389
181
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
1302.5
257.1
249
*
JFB43
NOMESCO Finland
Left hemicolectomy
38.6
254.8
327
90
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
154.0
250.1
264
18
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
241.9
248.3
254
11
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.3
247.8
714
1271
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
88.1
247.0
276
33
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
488.4
237.1
235
5
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
2194.2
229.6
221
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.9
229.0
558
779
D75
ICPC
Malignant neoplasm colon/rectum
29.5
217.1
297
106
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.6
204.8
1055
3373
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.6
204.2
560
923
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
401.4
195.2
195
5
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.6
194.4
535
884
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.3
194.1
803
2108
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.0
194.0
676
1489
B01AB10
ATC
tinzaparin; parenteral
4.3
187.4
763
1969
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
7.4
186.5
471
688
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
476.1
186.3
185
*
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
184.4
176
*
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
1822.9
174.8
169
*
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
358.4
174.4
175
5
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
136.7
173.4
185
14
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
12.5
173.3
322
272
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
258.1
171.5
175
7
JN4CD
NOMESCO Finland
Very extensive body CT
5.3
165.2
542
1108
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.3
162.4
414
610
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
332.7
161.9
163
5
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.8
160.1
488
913
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
5.2
157.2
527
1102
Z51.5
ICD-10 Finland
Palliative care
3.8
151.0
707
2047
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
149.9
2022
11312
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
146.4
1017
3945
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
17.6
145.1
233
138
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
188.7
141.3
147
8
8240/3-C18.2
ICD-O-3
Neuroendocrine tumor, NOS, of ascending colon
+∞
141.2
135
*
8240/3-C18.1
ICD-O-3
Neuroendocrine tumor, NOS, of appendix
+∞
138.1
132
*
C18
ICD-10 Finland
Malignant neoplasm of colon
237.5
135.6
139
6
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
153.7
127.8
135
9
JAH00
NOMESCO Finland
Laparotomy
5.9
125.6
371
663
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
8.1
125.3
295
383
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
123.4
576
1650
ZX120
NOMESCO Finland
Intravenous
3.0
122.9
790
2883
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
19.1
119.0
185
100
L01BC59
ATC
trifluridine, combinations; systemic
139.7
115.6
123
9
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
38.7
115.1
147
39
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
22.6
114.9
169
77
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
11.4
113.5
219
199
8140/3-C18.5
ICD-O-3
Adenocarcinoma, NOS, of splenic flexure of colon
+∞
111.8
107
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
112.4
111.4
121
11
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
559.1
111.3
110
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
110.5
109.4
119
11
WX402
NOMESCO Finland
General anaesthesia
2.5
109.0
995
4463
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
+∞
107.6
103
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
6.8
106.6
283
438
176
Kela drug reimbursment
Regorafenib
92.0
105.4
117
13
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
104.1
636
2225
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
103.6
697
2603
JFB00
NOMESCO Finland
Partial resection of small intestine
7.5
99.7
245
339
8480/3-C18.0
ICD-O-3
Mucinous adenocarcinoma of cecum
496.6
98.8
98
*
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
71.3
97.7
112
16
369
Kela drug reimbursment
Regorafenib
84.8
96.4
108
13
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
95.3
1381
7647
C18.39
ICD-10 Finland
Malignant tumor of flexura hepatica other or unspecified histology
244.1
93.9
96
*
A04AA01
ATC
ondansetron; systemic, rectal
3.1
89.7
530
1802
N02AA05
ATC
oxycodone; systemic
2.2
89.6
1135
5909
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.6
89.1
217
296
1XC07
NOMESCO Finland
NA
40.8
88.9
112
28
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
18.6
88.2
138
76
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
+∞
87.7
84
*
JFB50
NOMESCO Finland
Other resection of colon
33.5
87.4
115
35
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
439.5
87.3
87
*
JFB54
NOMESCO Finland
Laparoscopic resection of sigmoid colon with partial proctectomy
57.7
86.3
102
18
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
85.9
1797
11350
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
12.3
85.7
159
133
K56.7
ICD-10 Finland
Ileus, unspecified
6.4
84.4
232
376
JAL30
NOMESCO Finland
Omentectomy
10.3
83.1
168
167
N02BE01
ATC
paracetamol; systemic, rectal
2.0
82.5
4655
40301
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.1
81.4
486
1662
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.3
80.5
316
766
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
79.5
1862
12141
8480/3-C18.2
ICD-O-3
Mucinous adenocarcinoma of ascending colon
+∞
78.3
75
*
JFF10
NOMESCO Finland
Loop enterostomy
15.4
76.3
128
85
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
+∞
76.2
73
*
JAH01
NOMESCO Finland
Laparoscopy
4.0
75.1
317
822
JFB40
NOMESCO Finland
Resection of transverse colon
48.6
74.8
91
19
A02BC02
ATC
pantoprazole; systemic
1.7
74.4
3550
28435
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
195.1
74.3
77
*
JJB10
NOMESCO Finland
Atypcal resection of liver
31.8
72.9
97
31
L01XE21
ATC
[U] regorafenib; oral
100.2
72.0
79
8
C18.6
ICD-10 Finland
Malignant neoplasm: Descending colon
+∞
72.0
69
*
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.6
71.8
263
595
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
4.7
71.4
255
562
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.4
71.0
369
1137
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
5.7
69.3
208
377
C18.62
ICD-10 Finland
Malignant tumor of the descending colon carcinoma of the adenoma
341.3
67.7
68
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.6
67.1
321
926
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.2
66.7
266
654
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.4
66.5
209
400
C18.59
ICD-10 Finland
Malignant tumor in flexura lienalis other or unspecified histology
331.0
65.6
66
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
64.3
1089
6266
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.9
64.2
221
468
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
10.9
63.9
125
117
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.6
63.7
169
261
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
63.4
2565
19237
A04AD12
ATC
aprepitant; systemic
5.5
62.9
193
359
C18.69
ICD-10 Finland
Malignant tumor of colon descendens other or unspecified histology
+∞
62.6
60
*
E0000UV
ATC
NA
1.7
61.6
2003
14128
C18.5
ICD-10 Finland
Malignant neoplasm: Splenic flexure
+∞
61.6
59
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.1
61.1
362
1226
C18.12
ICD-10 Finland
Malignant tumor of the appendix carcinoma of the adenoma
+∞
60.5
58
*
6404
FHL
Hemicolectomy on the right
35.5
59.5
77
22
WW500
NOMESCO Finland
Blood transfusion
3.2
59.4
327
1050
Z31.5
ICD-10 Finland
Genetic counselling
4.0
58.3
249
651
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
58.2
381
1378
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
17.8
57.6
91
52
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
9.8
57.6
119
124
8480/3-C18.7
ICD-O-3
Mucinous adenocarcinoma of sigmoid colon
+∞
57.4
55
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.1
56.5
160
270
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
56.0
547
2477
C18.32
ICD-10 Finland
Malignant tumor of flexura hepatica carcinoma of adenoma
553.5
55.7
55
*
WX704
NOMESCO Finland
Intubation
2.6
55.2
447
1833
UJF34
NOMESCO Finland
Left colonoscopy
9.8
55.1
114
119
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.7
54.7
163
293
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.6
53.4
252
718
A04AA55
ATC
palonosetron, combinations; systemic
4.4
51.3
194
453
JKA20
NOMESCO Finland
Cholecystectomy
3.3
50.3
265
823
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
41.7
49.8
62
15
B01AB04
ATC
dalteparin; parenteral
2.7
49.7
374
1471
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
7.1
49.6
125
180
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
49.2
771
4269
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
48.9
752
4133
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.3
48.8
155
301
8140/3-C18.1
ICD-O-3
Adenocarcinoma, NOS, of appendix
+∞
48.0
46
*
C18.81
ICD-10 Finland
Malignant overall tumor of the colon invasive carcinoma
471.8
47.4
47
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
47.0
609
3125
8480/3-C18.4
ICD-O-3
Mucinous adenocarcinoma of transverse colon
+∞
46.9
45
*
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
27.0
46.4
64
24
D37.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Appendix
18.9
46.1
71
38
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
9.3
45.8
97
106
WX600
NOMESCO Finland
Single shot through catheter
6.5
45.7
122
191
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
+∞
44.8
43
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
44.5
962
5921
JFF13
NOMESCO Finland
Terminal enterostomy
23.1
44.4
64
28
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
19.9
44.4
67
34
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.4
44.3
168
394
8480/3-C18.9
ICD-O-3
Mucinous adenocarcinoma of colon, NOS
+∞
43.8
42
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.7
43.7
104
138
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
41.9
43.5
54
13
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
17.0
43.2
69
41
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.9
43.2
147
309
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
6.3
42.0
114
183
V03AF03
ATC
calcium folinate; systemic
20.2
41.3
62
31
JFF23
NOMESCO Finland
Transversostomy
5.4
41.2
128
243
Z93.3
ICD-10 Finland
Colostomy status
7.1
40.5
101
144
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
40.3
250
871
JEA01
NOMESCO Finland
Laparoscopic appendectomy
3.8
40.1
176
472
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
3.3
38.6
206
646
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
6.6
38.5
101
155
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
40.4
38.4
48
12
K92.1
ICD-10 Finland
Melaena
2.3
38.3
384
1751
JFB20
NOMESCO Finland
Ileocaecal resection
10.1
37.8
76
76
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.8
37.7
165
442
L01BC53
ATC
tegafur, combinations; systemic
26.2
37.6
52
20
C18.52
ICD-10 Finland
Malignant tumor of flexura lienalis carcinoma of adenoma
+∞
37.5
36
*
1534A
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]
+∞
37.5
36
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
37.4
371
1684
TJF80
NOMESCO Finland
Ostomy education
5.6
36.0
108
197
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.7
35.8
265
1028
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
80.7
35.8
40
5
C18.80
ICD-10 Finland
Malignant overall tumor of the colon without histology
98.2
35.7
39
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
7.5
35.4
85
115
R4110
NOMESCO Finland
Physiotherapy
1.5
35.2
1367
9764
3AC01
NOMESCO Finland
NA
5.8
34.9
101
177
TPX15
NOMESCO Finland
Removal of vascular injection port
10.6
34.7
68
65
K65.0
ICD-10 Finland
Acute peritonitis
4.9
34.6
116
241
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
36.1
33.7
43
12
JEA00
NOMESCO Finland
Appendectomy
2.4
33.5
307
1338
JJB71
NOMESCO Finland
Laparoscopic resection of liver
28.3
33.3
45
16
1533A
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]
329.0
32.9
33
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
32.7
351
1650
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
32.5
257
1038
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
2.4
32.4
300
1317
A79
ICPC
Malignancy NOS
4.1
30.8
124
310
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
46.5
30.6
37
8
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.8
30.3
197
708
JFC10
NOMESCO Finland
Ileotransversostomy
31.0
30.3
40
13
D77
ICPC
Malignant digestive neopl other/NOS
8.7
30.3
66
77
8480/3-C18.3
ICD-O-3
Mucinous adenocarcinoma of hepatic flexure of colon
+∞
30.2
29
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.3
30.1
159
497
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
7.7
29.6
69
90
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.4
29.2
109
254
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.4
29.0
144
430
JFA42
NOMESCO Finland
Endoscopic injection in colon
9.1
28.8
61
68
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
9.2
28.5
60
66
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
55.3
28.1
33
6
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
28.0
314
1507
SPAT1125
SPAT
Stoma care and guidance
3.2
27.8
148
465
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
6.0
27.7
77
129
WX110
NOMESCO Finland
Local anesthesy
1.4
27.5
3029
26002
8000/3-C18.9
ICD-O-3
Neoplasm, malignant of colon, NOS
+∞
27.1
26
*
SPAT1153
SPAT
Removal of sutures
1.4
27.0
1656
12845
Z93.2
ICD-10 Finland
Ileostomy status
11.2
27.0
51
46
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
13.2
26.4
46
35
UJG02
NOMESCO Finland
Proctoscopy
3.1
26.3
151
501
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
26.3
425
2355
R4190
NOMESCO Finland
Nutritional therapy
2.9
26.1
162
566
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
19.6
26.0
39
20
WX002
NOMESCO Finland
Sedation and analgesia
1.5
25.9
1032
7332
R50.9
ICD-10 Finland
Fever, unspecified
1.6
25.9
687
4430
JAQ10
NOMESCO Finland
Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity
261.8
25.7
26
*
KCD10
NOMESCO Finland
Partial cystectomy
24.1
25.6
36
15
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
8.3
25.2
56
68
JFH10
NOMESCO Finland
Total colectomy and ileostomy
14.6
25.1
42
29
JFG36
NOMESCO Finland
Closure of terminal colostomy with anastomosis to rectum
16.1
24.9
40
25
B80
ICPC
Iron deficiency anaemia
3.3
24.9
127
388
L03AA02
ATC
filgrastim; parenteral
2.8
24.7
168
622
1XC08
NOMESCO Finland
NA
90.5
24.7
27
*
D48.42
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum originating in the appendix
90.5
24.7
27
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
7.0
24.6
61
88
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.0
24.2
146
502
1536A
ICD-9 Finland
Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]
+∞
24.0
23
*
8243/3-C18.1
ICD-O-3
Goblet cell carcinoid of appendix
+∞
24.0
23
*
S18
ICPC
Laceration/cut
1.4
23.6
2103
17279
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.0
23.2
296
1500
K56.0
ICD-10 Finland
Paralytic ileus
4.1
23.1
91
224
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.9
23.0
146
519
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
54.2
23.0
27
5
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
6.3
22.8
61
98
JJB30
NOMESCO Finland
Excision of two segments of liver
19.0
22.5
34
18
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
22.5
396
2257
L03AA13
ATC
pegfilgrastim; parenteral
2.4
22.4
192
810
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
22.4
240
1128
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.7
22.3
97
262
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.4
22.2
81
186
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
22.1
525
3276
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
22.0
727
4934
WX882
NOMESCO Finland
High dependency care
2.6
21.9
164
645
JFH96
NOMESCO Finland
Other total colectomy
80.4
21.7
24
*
R11
ICD-10 Finland
Nausea and vomiting
1.8
21.7
391
2247
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
18.9
21.2
32
17
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.1
21.1
118
387
8210/3-C18.7
ICD-O-3
Adenocarcinoma in adenomatous polyp of sigmoid colon
+∞
20.8
20
*
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
17.9
20.8
32
18
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.6
20.7
72
158
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
5.9
20.5
57
97
R18
ICD-10 Finland
Ascites
2.9
20.4
124
430
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.0
20.3
81
203
ZX121
NOMESCO Finland
Central venous catheter
8.8
20.3
43
49
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
3.8
20.2
86
228
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
4.4
20.2
74
171
JFB63
NOMESCO Finland
Other resection of colon with proximal colostomy and closure of distal stump
32.6
20.2
26
8
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
20.1
149
583
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
19.9
493
3110
8244/3-C18.1
ICD-O-3
Mixed adenoneuroendocrine carcinoma of appendix
+∞
19.8
19
*
C18.89
ICD-10 Finland
Malignant overall tumor of the colon other or unspecified histology
73.7
19.7
22
*
8480/1-C18.1
ICD-O-3
Low grade appendiceal mucinous neoplasm of appendix
73.7
19.7
22
*
D50
ICD-10 Finland
Iron deficiency anaemia
3.3
19.7
101
312
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
6.1
19.6
53
87
C18.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of colon
200.6
19.6
20
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.8
19.5
82
216
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
2.4
19.4
163
683
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.8
19.4
129
475
D99
ICPC
Disease digestive system other
4.1
19.1
74
181
JJB20
NOMESCO Finland
Excision of single segment of liver
22.6
19.0
27
12
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
5.6
18.9
55
99
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
18.8
942
6965
C18.82
ICD-10 Finland
Malignant overall tumor of colon carcinoma of adenoma
100.4
18.6
20
*
J01MA12
ATC
levofloxacin; systemic
1.4
18.5
963
7167
SPAT1131
SPAT
Colonoscopy
2.2
18.5
188
866
JN4DD
NOMESCO Finland
Scout CT scan of torso
12.9
18.4
32
25
LAE10
NOMESCO Finland
Unilateral oophorectomy
8.2
18.1
40
49
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
8.9
18.1
38
43
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.5
17.8
82
234
15302
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Cacci
180.5
17.5
18
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
2.7
17.2
115
424
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
3.7
17.2
74
200
6434
FHL
Anterior resection
10.7
16.9
32
30
8240/3-C18.0
ICD-O-3
Neuroendocrine tumor, NOS, of cecum
+∞
16.7
16
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
JJA20
NOMESCO Finland
Open biopsy of liver
9.2
16.6
34
37
A06AH03
ATC
naloxegol; oral
3.5
16.4
76
218
D64.8
ICD-10 Finland
Other specified anaemias
2.7
16.4
110
408
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
10.0
16.4
32
32
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
16.2
372
2296
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.1
16.1
179
860
XQ902
NOMESCO Finland
Other photography
5.5
16.1
47
86
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
30.1
16.1
21
7
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
15.8
494
3297
Z43.2
ICD-10 Finland
Attention to ileostomy
12.2
15.8
28
23
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.3
15.8
80
247
8000/3-C18.7
ICD-O-3
Neoplasm, malignant of sigmoid colon
+∞
15.6
15
*
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
9.2
15.6
32
35
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
15.6
373
2327
P01AB01
ATC
metronidazole; oral, rectal
1.3
15.5
1649
13683
SPAT1109
SPAT
Analgesia with portable analgesic pump
4.5
15.3
54
122
JFF30
NOMESCO Finland
Other colostomy
13.9
15.0
25
18
JF2BD
NOMESCO Finland
Extensive colon CT
3.6
15.0
67
188
WX892
NOMESCO Finland
Monitored bed care
1.6
14.9
374
2365
E34.0
ICD-10 Finland
Carcinoid syndrome
7.4
14.6
34
46
B82
ICPC
Anaemia other/unspecified
2.2
14.6
141
637
3049
Kela drug reimbursment
NA
+∞
14.6
14
*
8000/3-C18.2
ICD-O-3
Neoplasm, malignant of ascending colon
+∞
14.6
14
*
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
80.3
14.6
16
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
6.0
14.5
39
65
QX9VV
NOMESCO Finland
NA
36.1
14.4
18
5
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
6.9
14.3
35
51
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
14.1
234
1310
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
13.9
768
5758
ZX100
NOMESCO Finland
Oral
2.9
13.8
85
300
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
5.3
13.7
41
78
WX290
NOMESCO Finland
Other blockade of nerve
1.3
13.7
1451
11987
LCD00
NOMESCO Finland
Hysterectomy
1.9
13.6
184
959
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
13.5
718
5336
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.6
13.5
61
173
L01BC04
ATC
carmofur; oral
16.2
13.4
21
13
JFC20
NOMESCO Finland
Other enterocolostomy
16.2
13.4
21
13
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
11.5
13.3
24
21
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
9.0
13.2
27
30
L01EX05
ATC
regorafenib; oral
40.1
13.1
16
*
Z43.3
ICD-10 Finland
Attention to colostomy
7.9
13.0
29
37
N02AX02
ATC
tramadol; systemic, rectal
1.2
12.8
2027
17548
WX004
NOMESCO Finland
Patient-controlled sedation
5.0
12.7
40
81
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
9.7
12.7
25
26
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
3.6
12.6
55
152
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
8.2
12.5
27
33
8480/3-C18.8
ICD-O-3
Mucinous adenocarcinoma of overlapping lesion of colon
+∞
12.5
12
*
15311
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Transverse colon, including hepatic and splenic flexures
+∞
12.5
12
*
8480/3-C18.6
ICD-O-3
Mucinous adenocarcinoma of descending colon
+∞
12.5
12
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
8.7
12.5
26
30
JFG29
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to rectum
20.1
12.4
18
9
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
3.3
12.4
62
191
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
5.6
12.3
35
63
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
37.6
12.2
15
*
JFB41
NOMESCO Finland
Laparoscopic resection of transverse colon
37.6
12.2
15
*
SPAT1255
SPAT
Intravenous administration of medicine
1.6
12.2
319
2042
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.4
12.1
31
49
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
3.8
12.1
50
133
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.7
12.0
83
315
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
6.8
11.9
29
43
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
11.9
178
962
JAD10
NOMESCO Finland
Repair of incisional hernia
3.5
11.8
54
156
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
7.9
11.8
26
33
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
3.8
11.8
48
126
JFB96
NOMESCO Finland
Other partial excision of intestine
12.5
11.6
20
16
1XA03
NOMESCO Finland
NA
65.1
11.6
13
*
JFF26
NOMESCO Finland
Sigmoidostomy
8.1
11.5
25
31
1531A
ICD-9 Finland
Malignant neoplasm of colon, Transverse colon[NEOPL MALIG COLI TRANSV,INVASIIVINEN KARSINOOMA]
+∞
11.5
11
*
15301
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Appendicis
+∞
11.5
11
*
JWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gastroenterological surgery
6.3
11.3
29
46
XX_20
NOMESCO Finland
Bioimpedance measurement
15.0
11.3
18
12
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
4.1
11.3
42
102
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
5.1
11.2
34
67
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
11.1
131
650
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
2.3
11.1
98
427
K63.5
ICD-10 Finland
Polyp of colon
2.7
10.9
70
257
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.3
10.9
54
167
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
3.8
10.8
44
116
1534X
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,EI HISTOLOGISTA VAHVISTUSTA]
+∞
10.4
10
*
8480/3-C18.5
ICD-O-3
Mucinous adenocarcinoma of splenic flexure of colon
+∞
10.4
10
*
8249/3-C18.0
ICD-O-3
Neuroendocrine tumor, grade 2 of cecum
+∞
10.4
10
*
JFA70
NOMESCO Finland
Suture of small intestine
5.1
10.3
31
61
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
7.1
10.2
24
34
KBV10
NOMESCO Finland
Removal of stent from ureter
3.9
10.2
41
107
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
6.2
10.1
26
42
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
10.1
104
487
WX872
NOMESCO Finland
Intensive care
1.6
10.1
235
1461
Z93
ICD-10 Finland
Artificial opening status
5.6
10.1
28
50
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.9
10.1
59
205
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.7
10.0
67
251
H01CB03
ATC
lanreotide; parenteral
5.5
9.9
28
51
6406
FHL
Other column resection
8.1
9.8
21
26
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
26.0
9.8
13
5
JFG26
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to colon
26.0
9.8
13
5
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.1
9.7
*
331
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
9.7
496
3661
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.8
9.7
39
103
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
3.3
9.6
46
139
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
5.3
9.6
28
53
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.2
9.5
48
151
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
9.5
856
6881
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
15.0
9.5
15
10
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
2.8
9.5
60
218
D01
ICPC
Abdominal pain/cramps general
1.5
9.4
363
2540
WW200
SPAT
NA
0.6
9.4
153
2471
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
4.8
9.4
30
63
8490/3-C18.0
ICD-O-3
Signet ring cell carcinoma of cecum
+∞
9.4
9
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
9.3
651
8175
RD211
NOMESCO Finland
NA
1.7
9.3
176
1032
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
9.3
1117
9311
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
9.2
154
867
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
4.4
9.1
31
70
SPAT1262
SPAT
Handing over of treatment supplies
1.3
9.1
887
7205
NK6LA
NOMESCO Finland
Bone and joint kinetic X-ray examination
8.3
9.0
19
23
ZXC40
NOMESCO Finland
Use of ultrasound
3.5
9.0
40
115
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
4.7
9.0
29
62
WGA11
NOMESCO Finland
Planning of pain management
7.9
8.8
19
24
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
7.9
8.8
19
24
SPAT1088
SPAT
Blood transfusion
3.6
8.8
37
102
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
4.3
8.8
31
73
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.6
8.8
60
230
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.0
8.8
110
560
R10.0
ICD-10 Finland
Acute abdomen
1.9
8.7
124
662
15331
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Sigmoid colon
50.1
8.7
10
*
A06AD11
ATC
lactulose; oral
1.3
8.6
781
6279
TJG20
NOMESCO Finland
Transanal irrigation
6.6
8.6
21
32
JFA68
NOMESCO Finland
Endoscopic insertion of prosthetic tube into colon
16.3
8.5
13
8
JJA40
NOMESCO Finland
Excision of lesion of liver
20.0
8.5
12
6
6407
FHL
Colectomy and ileorectostomy
20.0
8.5
12
6
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
8.4
280
1900
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
7.8
8.3
18
23
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
7.8
8.3
18
23
15303
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Coli ascendentis
+∞
8.3
8
*
1532A
ICD-9 Finland
Malignant neoplasm of colon, Descending colon[NEOPL MALIG COLI DESCEND,INVASIIVINEN KARSINOOMA]
+∞
8.3
8
*
8000/3-C18.0
ICD-O-3
Neoplasm, malignant of cecum
+∞
8.3
8
*
8144/3-C18.7
ICD-O-3
Adenocarcinoma, intestinal type of sigmoid colon
+∞
8.3
8
*
1535C
ICD-9 Finland
Malignant neoplasm of colon, Appendix[NEOPL MALIG APPEND VERMIF,MUU TAI MÄÄRITTELEMÄTÖN H]
+∞
8.3
8
*
D07AA02
ATC
hydrocortisone; topical
1.4
8.3
490
3704
UJK02
NOMESCO Finland
ERCP
1.8
8.2
128
707
KBV00
NOMESCO Finland
Insertion of stent into ureter
3.7
8.2
34
93
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
8.2
256
1718
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.0
8.1
21
35
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.7
8.0
149
872
SPAT1078
SPAT
Removal of central venous or arterial cannula
8.9
8.0
16
18
JFW98
NOMESCO Finland
Other transluminal endoscopic operation on intestine
22.0
8.0
11
5
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.3
8.0
71
313
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
8.0
86
413
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
7.9
265
1801
TJA10
NOMESCO Finland
Laparocentesis
4.9
7.9
24
49
KCH00
NOMESCO Finland
Suture of bladder
6.6
7.9
19
29
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.8
1870
16649
D16
ICPC
Rectal bleeding
2.0
7.8
90
448
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.0
7.8
92
462
JAH33
NOMESCO Finland
Opening of laparostomy
6.9
7.8
18
26
6405
FHL
Hemicolectomy on the left
6.9
7.8
18
26
N05AX08
ATC
risperidone; systemic
0.6
7.7
165
2509
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
4.8
7.4
23
48
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
7.4
608
4821
1533X
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,EI HISTOLOGISTA VAHVISTUSTA]
80.2
7.4
8
*
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.6
7.4
52
204
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.3
7.4
67
298
JFC00
NOMESCO Finland
Entero-enterostomy
6.4
7.4
18
28
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
6.4
7.4
18
28
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
7.6
7.4
16
21
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
7.6
7.4
16
21
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
2.1
7.3
73
342
C10AX09
ATC
ezetimibe; oral
0.7
7.3
271
3730
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
3.5
7.3
32
92
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.8
7.3
43
152
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
8.4
7.3
15
18
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.4
7.3
59
251
8246/3-C18.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of appendix
+∞
7.3
7
*
8010/3-C18.4
ICD-O-3
Carcinoma, NOS, of transverse colon
+∞
7.3
7
*
8010/3-C18.9
ICD-O-3
Carcinoma, NOS, of colon, NOS
+∞
7.3
7
*
K62.1
ICD-10 Finland
Rectal polyp
2.5
7.2
54
218
JFC30
NOMESCO Finland
Colo-colostomy
15.7
7.2
11
7
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
15.7
7.2
11
7
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
5.4
7.2
20
37
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
7.3
7.2
16
22
OAB42
SPAT
NA
0.5
7.2
52
1040
JFF24
NOMESCO Finland
Laparoscopic transversostomy
12.0
7.1
12
10
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.6
7.0
49
192
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
4.9
6.9
21
43
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
2.3
6.9
59
257
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
6.9
260
1814
JA3CT
NOMESCO Finland
Cathetrisation of abdominal cavity with CT guidance
6.3
6.9
17
27
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
5.1
6.9
20
39
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
5.8
6.9
18
31
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
7.5
6.9
15
20
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
2.1
6.9
71
336
H01CB02
ATC
octreotide; parenteral
3.9
6.8
26
67
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.2
6.8
67
313
Z01.8
ICD-10 Finland
Other specified special examinations
1.2
6.8
876
7329
J01DB01
ATC
cefalexin; oral
1.2
6.8
3760
35657
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
5.0
6.8
20
40
JG1BG
NOMESCO Finland
MRI of rectum
3.1
6.7
34
110
K83.1
ICD-10 Finland
Obstruction of bile duct
2.2
6.7
65
299
B03BA03
ATC
hydroxocobalamin; parenteral
1.4
6.7
288
2063
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
3.0
6.7
36
122
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
2.6
6.6
44
169
KA1FN
NOMESCO Finland
Isotope renography
2.9
6.6
36
123
M25.5
ICD-10 Finland
Pain in joint
0.8
6.6
730
8735
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.9
6.6
87
456
WF004
NOMESCO Finland
Palliative radiotherapy
1.9
6.6
93
499
JAL00
NOMESCO Finland
Biopsy of peritoneum
3.4
6.6
29
85
JJA43
NOMESCO Finland
Destruction of lesion of liver
12.2
6.6
11
9
A41.9
ICD-10 Finland
Sepsis, unspecified
1.6
6.6
169
1085
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
4.8
6.5
20
42
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
6.5
806
9531
E86
ICD-10 Finland
Volume depletion
1.7
6.5
120
705
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
4.2
6.4
22
52
K63.9
ICD-10 Finland
Disease of intestine, unspecified
3.2
6.4
31
98
B02AA02
ATC
tranexamic acid; systemic
1.3
6.4
438
3391
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
6.5
6.3
15
23
K91.3
ICD-10 Finland
Postoperative intestinal obstruction
8.1
6.3
13
16
R03AC02
ATC
salbutamol; inhalant
0.9
6.3
1781
19665
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
6.3
663
5426
K37
ICD-10 Finland
Unspecified appendicitis
3.8
6.3
24
63
15321
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Descending colon
+∞
6.2
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
2.1
6.2
62
291
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.8
6.2
432
5444
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
6.2
270
1941
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
0.7
6.2
187
2663
M01AC06
ATC
meloxicam; systemic, rectal
0.8
6.1
1206
13704
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
6.1
690
5689
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.3
6.1
51
222
WX610
NOMESCO Finland
Patient controlled analgesia
3.7
6.1
24
65
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.7
6.0
116
688
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
4.9
6.0
18
37
D74
ICPC
Malignant neoplasm stomach
6.7
6.0
14
21
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
6.0
1179
10275
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1358
4717
3.44
310.85
2.5
2.1
g/l
0.2
0.2
0.05
1303
4342
(3022145) Colonoscopy Study observation
1962
4939
5.44
307.65
1.5
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
692
1070
7.19
307.65
5.7
2.9
u/ml
216.5
795.8
1.40
633
976
(4035726)
1311
4310
3.62
307.65
1.4
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1309
1811
8.99
307.65
5.8
3.0
u/ml
2080.3
3006.5
0.23
1170
1539
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
4144
5233
23.89
307.65
9.2
3.2
ug/l
31.8
21.8
1.03
3828
4249
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4050
25977
2.76
283.69
14.2
6.0
umol/l
12.0
12.1
0.15
3947
24544
(3044640) Blood type and Crossmatch panel - Blood
2868
15661
2.61
278.68
3.2
2.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3654
22514
2.62
273.75
9.6
4.7
g/l
33.3
34.7
36.63
3507
20633
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3612
22347
2.57
264.72
5.4
4.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2239
11937
2.41
215.11
2.9
2.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1622
7749
2.50
195.44
2.2
2.6
g/l
2.4
2.3
25.33
1554
7090
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1554
7292
2.53
194.46
2.3
2.6
%
17.5
21.8
30.55
1377
6098
(3022948) Iron [Moles/volume] in Serum or Plasma
1701
8355
2.45
192.50
2.3
2.6
umol/l
10.4
12.2
18.56
1616
7637
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2382
13557
2.26
191.16
2.4
2.3
mg/l
4.2
3.0
43.71
2085
11429
(3037121) Protein [Mass/volume] in Urine
598
1764
3.66
170.64
5.9
2.8
g/l
0.2
0.3
9.22
450
687
(3023368) Bacteria identified in Blood by Culture
2522
15451
2.10
160.40
5.0
4.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2523
15587
2.08
155.60
3.0
2.5
u/l
54.5
58.6
3.58
2397
14267
(3013650) Neutrophils [#/volume] in Blood by Automated count
3779
27074
2.09
154.50
16.1
8.6
e9/l
4.0
4.3
8.36
3424
23372
(3033658) Prothrombin time (PT) actual/Normal
2107
12304
2.10
149.88
5.5
4.0
%
86.0
85.1
0.83
2076
11995
(40768804) Tissue Pathology biopsy report
2859
18726
2.02
147.52
2.7
2.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3237
22316
1.99
142.42
10.1
11.0
inr
1.3
1.3
3.10
849
6088
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1127
5412
2.34
127.87
3.2
2.7
umol/l
10.4
9.4
0.53
1023
4678
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2776
18791
1.90
122.22
3.1
2.9
ug/l
116.8
155.0
11.60
2560
16935
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4640
37380
2.10
119.15
15.6
7.5
u/l
94.2
80.7
23.88
4495
34870
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
889
3958
2.47
118.91
1.7
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
272
589
4.79
116.92
2.1
2.3
u/ml
352.9
824.7
0.41
266
577
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1648
10084
1.88
93.54
9.1
3.0
mmol/l
2.5
2.5
5.33
1547
8722
(3013826) Glucose [Moles/volume] in Serum or Plasma
3803
29768
1.77
92.10
6.0
4.8
mmol/l
6.9
6.9
0.53
3646
27987
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
888
4440
2.18
88.66
2.7
2.4
u/l
37.5
38.2
0.06
812
3779
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3432
26295
1.72
87.59
8.2
6.7
mmol/l
1.2
1.2
15.70
2905
21996
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1430
8520
1.89
87.24
4.9
3.0
mmol/l
0.8
0.8
6.61
1362
7847
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
237
580
4.21
87.10
4.4
3.4
nmol/l
7.4
17.4
0.51
231
566
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
508
2063
2.60
81.11
2.5
2.8
u/ml
0.3
0.3
1.58
305
1184
(3015377) Calcium [Moles/volume] in Serum or Plasma
2448
17531
1.67
76.85
7.8
3.3
mmol/l
2.3
2.4
0.83
2223
14899
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2086
14324
1.70
76.73
4.9
3.2
u/l
40.8
36.7
0.37
1991
13452
(3014576) Chloride [Moles/volume] in Serum or Plasma
1192
6963
1.89
75.96
8.4
6.3
mmol/l
105.0
104.3
5.79
1167
6798
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3125
23892
1.65
75.45
7.2
5.9
mmol/l
1.2
1.2
9.42
2904
21393
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
625
2981
2.23
69.23
8.5
8.9
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
51
24
21.43
68.27
1.0
1.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
937
5337
1.90
63.43
8.0
7.2
g/l
114.4
120.2
16.88
910
5137
(3016502) Oxygen saturation in Arterial blood
1004
5868
1.86
62.62
7.7
6.7
%
96.5
95.3
7.26
976
5629
(3020779) Urea [Moles/volume] in Serum or Plasma
892
5023
1.91
62.45
5.7
6.7
mmol/l
9.6
11.1
7.02
848
4741
(40758558) Short blood count panel - Blood
1751
11985
1.65
62.30
12.4
6.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1169
7223
1.77
60.41
2.1
2.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1066
6523
1.77
56.56
7.4
6.4
mmol/l
0.6
1.1
3.36
850
5016
(3002030) Lymphocytes/100 leukocytes in Blood
2861
22353
1.54
56.11
5.4
6.1
%
23.9
26.2
21.29
2649
20505
(3019069) Monocytes/100 leukocytes in Blood
2818
21954
1.54
55.93
5.4
6.2
%
9.0
8.9
1.31
2623
20289
(3006504) Eosinophils/100 leukocytes in Blood
2805
21841
1.54
55.74
5.2
5.9
%
2.7
2.8
3.55
2610
20112
(3014111) Lactate [Moles/volume] in Serum or Plasma
842
4831
1.87
55.12
6.1
6.1
mmol/l
1.3
1.4
0.61
805
4636
(3027801) Oxygen [Partial pressure] in Arterial blood
1061
6548
1.76
54.44
7.5
6.4
kpa
13.6
11.9
18.98
1020
6203
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1061
6550
1.75
54.38
7.5
6.4
kpa
5.1
5.1
0.43
1022
6210
(3022096) Basophils/100 leukocytes in Blood
2731
21250
1.53
53.73
5.2
5.9
%
0.6
0.7
8.68
2541
19589
(3027945) Reticulocytes/100 erythrocytes in Blood
1081
6747
1.74
53.17
1.9
2.4
%
1.8
1.8
0.90
951
5887
(3003694) ABO and Rh group [Type] in Blood
1632
11379
1.60
52.04
1.4
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2199
16453
1.53
51.13
4.8
5.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2791
22000
1.51
50.48
5.2
5.8
%
60.3
58.5
10.43
2607
20285
(3006315) Basophils [#/volume] in Blood
2927
23340
1.50
49.80
4.9
5.6
e9/l
0.0
0.0
3.76
2497
19829
(3001604) Monocytes [#/volume] in Blood
2902
23198
1.49
48.13
4.9
5.6
e9/l
0.6
0.6
2.18
2473
19684
(3019198) Lymphocytes [#/volume] in Blood
2959
23748
1.49
48.11
5.0
5.7
e9/l
1.8
1.9
0.52
2573
20486
(3000991) Gas panel - Venous blood
780
4558
1.82
47.67
7.2
7.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
2986
24095
1.48
46.69
5.1
5.8
e9/l
0.2
0.2
2.64
2586
20741
(3026782) Osmolality of Urine
1510
10594
1.57
45.85
3.1
2.9
mosm/kgh2o
549.7
548.1
0.10
1332
9009
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
303
1259
2.48
45.65
2.0
2.4
g/l
3.7
3.6
0.44
296
1194
(40768441) Liver Pathology biopsy report
123
303
4.12
44.82
1.1
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2099
15891
1.50
44.46
3.6
3.5
e6/l
47.4
96.2
2.85
1709
12371
(3031040) Bacteria [#/volume] in Urine by Automated count
3814
32598
1.48
42.53
4.9
5.1
e6/l
2270.8
2128.7
0.04
54
552
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1061
6966
1.64
42.06
4.9
5.6
mmol/l
1.0
1.0
1.13
985
6395
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
399
1939
2.13
41.54
2.8
4.0
u/ml
62.4
78.6
0.69
390
1854
(3002256) Pathology report gross observation
980
6358
1.65
40.60
1.4
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
361
1733
2.15
38.74
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3268
27420
1.43
38.05
3.8
3.2
u/l
73.8
54.9
10.30
3061
24820
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
266
1140
2.40
37.41
1.9
2.3
%
213.9
202.0
1.34
256
1081
(40768797) Stomach Pathology biopsy report
990
6569
1.61
37.13
1.2
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1902
14541
1.45
36.52
3.5
3.4
e6/l
0.5
0.5
0.13
1528
11123
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
277
1224
2.32
36.34
1.9
2.1
%
81.4
88.9
5.44
269
1160
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
450
2421
1.93
35.21
1.9
1.9
ug/l
1.5
2.4
1.74
403
2084
(36304419) Bacteria [Presence] in Urine
1817
13959
1.43
33.28
3.4
3.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
947
6392
1.57
32.65
3.1
4.1
u/l
243.8
247.6
0.33
901
5983
(3018095) Leukocytes [#/volume] in Urine
2254
18038
1.40
32.56
4.1
4.0
e6/l
95.5
120.2
0.91
1769
13197
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
511
2941
1.81
32.26
2.6
2.5
—
—
—
0
0
(3039000) Anion gap in Blood
270
1245
2.22
32.01
7.8
6.7
mmol/l
11.2
11.3
0.24
248
1112
(3018572) Chloride [Moles/volume] in Blood
270
1245
2.22
32.01
7.8
6.7
mmol/l
106.1
105.0
3.17
248
1112
(3023520) Reticulocytes [#/volume] in Blood
788
5115
1.62
31.97
2.0
2.5
e9/l
70.5
68.2
0.85
619
3897
(3007930) Methemoglobin/Hemoglobin.total in Blood
428
2366
1.87
30.74
6.2
5.0
%
0.9
0.9
0.63
402
2219
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
429
2393
1.85
29.93
6.0
4.9
%
1.6
1.6
0.24
405
2243
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
498
2919
1.77
29.49
8.2
8.2
mmol/l
23.8
24.3
2.62
484
2689
(3025941) Bacteria identified in Stool by Culture
417
2322
1.86
29.25
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
1973
15668
1.39
28.90
4.7
4.0
ph
7.4
7.4
2.80
424
2941
(3000850) Epithelial cells [#/volume] in Urine
1494
11308
1.43
28.90
2.8
2.7
e6/l
5.4
4.8
1.12
1332
9892
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1150
8354
1.47
27.51
2.0
2.0
s
30.1
30.1
0.03
1122
8086
(3037467) Urinalysis macro (dipstick) panel - Urine
3764
33221
1.36
27.50
5.5
4.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1508
11539
1.41
27.13
1.8
1.8
nmol/l
1192.8
1168.3
0.39
1147
8557
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4929
45584
1.48
27.09
28.2
17.1
mg/l
37.0
26.4
64.40
4562
37222
(3021447) Carbon dioxide [Partial pressure] in Venous blood
781
5263
1.56
26.71
3.5
3.7
kpa
5.6
5.8
8.51
757
5085
(3026008) Bacteria identified in Urine by Culture
2051
16593
1.36
26.06
3.4
3.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
323
1720
1.93
25.96
7.2
6.0
mmol/l
1.4
1.3
1.00
292
1528
(3002032) Base excess in Venous blood by calculation
775
5254
1.55
25.74
3.5
3.7
mmol/l
1.7
1.9
0.63
599
4230
(3019060) Gas panel - Arterial blood
607
3909
1.62
25.12
6.1
4.5
—
—
—
0
0
(4281824)
129
473
2.77
25.10
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
572
3675
1.62
23.86
8.5
6.5
mmol/l
24.2
24.5
1.61
543
3429
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1126
8356
1.43
23.61
3.2
3.2
e6/l
2.8
2.2
1.43
678
4698
(3036489) Thrombin time
297
1617
1.88
22.32
1.9
1.9
s
21.4
21.7
0.44
280
1454
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
160
724
2.24
19.94
5.8
6.3
mg/l
11.8
12.3
0.64
143
661
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
437
2761
1.63
19.42
1.4
1.7
g/l
1.7
1.5
4.56
377
2346
(3019225) pH of Specimen
765
5474
1.46
19.19
4.9
4.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
130
551
2.39
18.87
1.2
1.1
g/l
1.6
1.6
0.70
124
487
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
48
118
4.09
17.71
2.1
2.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
471
3125
1.55
16.98
6.9
6.5
mmol/l
24.4
24.9
1.69
466
3097
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
143
672
2.16
16.30
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1174
9253
1.33
16.28
1.9
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
261
1506
1.77
16.27
1.7
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
397
2564
1.59
16.09
3.2
3.9
mmol/l
23.6
24.1
1.68
363
2282
(3033799) Differential panel - Peritoneal fluid
54
158
3.44
15.58
1.4
1.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
609
4334
1.45
15.58
3.1
3.1
kpa
4.6
4.5
0.66
586
4170
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
138
657
2.13
15.25
1.4
1.4
—
—
—
0
0
(3013512) EKG study
1841
15515
1.27
15.24
4.6
4.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
483
3312
1.50
14.90
1.5
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
203
1125
1.83
14.51
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
136
658
2.09
14.43
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
136
658
2.09
14.43
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
137
665
2.09
14.41
1.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2524
22166
1.24
14.31
2.2
2.1
pmol/l
89.4
93.2
3.63
1458
11452
(3005988) Vibrio sp identified in Specimen by Organism specific culture
136
661
2.08
14.26
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1123
8954
1.31
14.13
3.1
3.0
e6/l
1.3
1.2
0.29
670
5256
(3021589) Normoblasts [#/volume] in Blood
2334
20392
1.24
13.67
14.8
10.2
e9/l
0.0
0.0
1.00
1889
16577
(3019550) Sodium [Moles/volume] in Serum or Plasma
5037
47970
1.33
13.43
33.5
20.2
mmol/l
139.3
139.6
16.18
4952
46641
(3023103) Potassium [Moles/volume] in Serum or Plasma
5041
48055
1.32
13.03
33.5
20.4
mmol/l
4.0
4.0
7.93
4947
46657
(40761511) CBC panel - Blood by Automated count
4886
46426
1.30
12.60
28.5
16.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
260
1609
1.64
12.59
4.8
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2342
20627
1.22
12.29
4.1
4.1
ng/l
44.0
82.9
1.06
1895
15771
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
601
4475
1.38
11.81
4.5
3.9
mmol/l
1.2
1.2
1.03
551
3874
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
725
5575
1.34
11.58
4.7
3.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
212
1288
1.67
11.06
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
210
1277
1.67
10.92
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
747
5824
1.32
10.82
1.8
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
211
1295
1.65
10.60
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1010
12232
0.79
10.23
1.7
1.6
mmol/l
1.4
1.3
2.29
841
10081
(3004119) Hemoglobin [Mass/volume] in Venous blood
470
3449
1.39
10.06
3.2
3.3
g/l
120.6
127.4
8.06
458
3359
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1214
10161
1.24
9.92
1.7
1.7
mg/l
1.8
1.4
2.82
992
7891
(40760892) CBC W Ordered Manual Differential panel - Blood
1129
9376
1.25
9.89
4.0
4.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
345
2402
1.46
9.88
1.9
1.9
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
181
1098
1.67
9.55
1.2
1.2
titre
60.0
94.1
1.97
14
79
(3023487) Leukocytes [#/volume] in Peritoneal fluid
48
177
2.73
9.48
1.5
2.1
e6/l
12028.9
5290.1
0.24
37
123
(3027273) Bicarbonate [Moles/volume] in Venous blood
396
2855
1.41
9.40
3.6
3.4
mmol/l
24.7
25.2
2.09
387
2765
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1257
10627
1.23
9.28
3.9
4.1
ng/l
440.3
464.5
0.04
1066
9095
(3009542) Hematocrit [Volume Fraction] of Blood
4171
39361
1.20
9.10
30.6
18.4
%
36.7
38.7
23.92
2609
24594
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
127
712
1.80
8.90
2.0
3.7
u/ml
18.2
36.7
3.91
122
690
(3017181) Myelocytes/100 leukocytes in Blood
545
4175
1.34
8.88
3.2
4.0
%
1.0
1.0
0.07
209
1254
(3018405) Lactate [Moles/volume] in Arterial blood
298
2067
1.47
8.73
5.0
3.7
mmol/l
1.4
1.4
0.03
293
2030
(3023183) Ammonium ion [Moles/volume] in Plasma
175
1079
1.64
8.71
2.2
2.6
umol/l
30.4
34.6
1.76
146
891
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4482
42641
1.21
8.69
28.6
16.2
ml/min/173m2
75.4
73.5
7.95
4025
35341
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
216
1402
1.56
8.68
1.4
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
519
3970
1.34
8.54
3.1
4.0
%
0.2
0.1
0.20
197
1172
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4984
47953
1.24
8.53
18.9
11.1
u/l
25.2
25.3
0.02
4869
45767
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
314
2216
1.44
8.41
1.8
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
985
8202
1.24
8.30
27.3
29.6
inr
1.4
1.5
0.73
157
1123
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
42
157
2.69
8.13
1.5
1.9
e6/l
15623.1
20171.7
0.11
31
87
(3012501) Base excess in Blood by calculation
194
1251
1.57
8.05
4.4
4.6
mmol/l
2.7
2.7
0.02
141
865
(3013290) Carbon dioxide [Partial pressure] in Blood
194
1252
1.57
8.02
4.4
4.7
kpa
5.0
5.0
0.06
189
1224
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
277
1928
1.46
8.00
2.0
2.1
ug/l
380.2
622.9
1.19
268
1822
(3027315) Oxygen [Partial pressure] in Blood
194
1260
1.56
7.81
4.4
4.7
kpa
8.9
8.4
2.34
189
1231
(3021960) Folate [Moles/volume] in Serum or Plasma
1496
13090
1.19
7.52
1.6
1.6
nmol/l
20.6
20.1
0.39
1287
11042
(3002385) Erythrocyte distribution width [Ratio]
3838
36197
1.17
7.49
36.8
20.6
%
14.8
13.9
139.62
3791
35268
(3002179) Metamyelocytes/100 leukocytes in Blood
488
3783
1.32
7.33
3.0
3.9
%
0.8
0.7
0.70
138
886
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
560
7004
0.78
7.20
1.3
1.3
iu/ml
44.2
38.0
0.44
188
2157
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4169
43628
0.85
7.17
4.3
4.7
mmol/l
1.4
1.4
2.25
3703
39136
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4215
44065
0.85
7.13
4.3
4.7
mmol/l
4.4
4.5
1.90
3781
39823
(3004809) Band form neutrophils/100 leukocytes in Blood
149
936
1.61
6.96
2.6
3.7
%
1.8
1.5
0.38
115
701
(3010421) pH of Blood
213
1449
1.49
6.95
4.2
4.5
ph
7.4
7.4
0.13
189
1226
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
18
44
4.10
6.80
1.2
1.6
%
61.6
61.0
0.02
13
29
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
348
2603
1.36
6.68
2.7
2.6
%
0.7
0.7
0.60
341
2490
(3020891) Body temperature
314
2313
1.38
6.64
5.8
4.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
771
6399
1.24
6.62
1.8
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
228
1589
1.45
6.60
5.2
4.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
387
2950
1.33
6.56
3.0
2.9
e6/l
0.3
0.3
0.00
382
2893
(40761536) Microorganisms panel - Urine sediment
511
4048
1.29
6.54
4.3
4.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
503
3983
1.29
6.46
3.8
2.7
ml/min/173m2
63.2
61.1
0.68
242
1687
(3004716) Salmonella sp identified in Stool by Organism specific culture
241
1706
1.43
6.43
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
36
142
2.54
6.34
1.8
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
128
794
1.63
6.33
2.6
2.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
473
3727
1.29
6.31
1.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1361
11975
1.18
6.24
4.4
3.8
—
—
—
0
0
(3044889) 12 lead EKG panel
3551
33526
1.15
6.11
4.5
4.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
500
3985
1.28
6.10
1.3
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
184
1250
1.49
6.10
3.6
3.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
83
462
1.81
6.09
1.3
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
16
39
4.11
6.08
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
467
3693
1.29
6.07
3.1
4.0
%
0.0
0.4
1.57
153
971
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
534
6581
0.79
6.03
1.2
1.2
u/ml
22.6
13.9
1.03
199
2321
(3000570) Elastase.pancreatic [Mass/mass] in Stool
211
1479
1.44
5.96
1.4
1.4
ug/g
244.5
267.3
0.87
137
900
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
75
411
1.84
5.80
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
182
1254
1.47
5.65
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
182
1254
1.47
5.65
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
60
310
1.94
5.56
2.5
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
5081
49403
1.20
5.49
43.4
24.9
fl
91.1
91.7
14.58
5017
48410
(3026361) Erythrocytes [#/volume] in Blood
5081
49406
1.20
5.47
43.6
25.0
e12/l
4.3
4.4
73.93
4970
47625
(3007461) Platelets [#/volume] in Blood
5080
49396
1.20
5.47
43.6
25.0
e9/l
251.9
241.4
19.10
4987
47809
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
140
921
1.53
5.45
3.3
3.6
%
58.5
58.7
0.03
140
921
(3035941) MCH [Entitic mass]
5080
49402
1.20
5.43
43.4
24.8
pg
30.0
30.4
46.08
5015
48410
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
755
6378
1.21
5.43
1.8
1.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
5081
49416
1.20
5.41
43.9
25.1
g/l
126.3
133.2
167.93
5017
48435
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1318
11686
1.16
5.40
1.7
1.7
pmol/l
5653803.9
25066787.3
2.04
1079
9419
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1928
17570
1.14
5.39
3.0
3.2
ng/l
1770.0
1801.6
0.09
1658
15259
(3051651) Icteric interference index of Serum or Plasma
60
315
1.91
5.33
6.8
3.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
5080
49419
1.19
5.32
43.6
25.0
e9/l
7.0
6.9
3.44
4979
47628
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
976
8466
1.18
5.24
1.2
1.2
u/ml
2.1
1.7
0.35
243
2133
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
72
404
1.79
5.20
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
95
579
1.65
5.12
5.3
3.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
168
1166
1.45
5.06
1.3
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
636
5330
1.22
4.96
3.2
3.0
ng/l
221.6
239.8
0.54
584
4892
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4131
42897
0.88
4.88
6.6
6.5
mmol/mol
41.4
40.8
2.92
3707
38895
(40767503) Oxygen content in Capillary blood by calculation
172
1214
1.43
4.76
2.3
2.5
%
15.5
15.9
0.58
84
627
(3028626) Oxygen [Partial pressure] in Capillary blood
179
1273
1.42
4.75
3.8
2.9
kpa
8.0
7.9
0.33
167
1167
(3013727) Leukocytes other/100 leukocytes in Blood
41
196
2.10
4.75
2.3
3.5
%
53.8
55.3
0.18
41
185
(3013707) Erythrocyte sedimentation rate by Westergren method
3646
34749
1.13
4.74
3.9
4.2
mm/h
18.2
14.2
28.45
3280
31683
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4379
45265
0.88
4.69
4.8
5.4
mmol/l
2.5
2.6
3.09
3902
40734
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
78
464
1.69
4.64
2.6
3.7
u/ml
49.6
46.1
0.05
78
457
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
55
295
1.87
4.63
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
55
295
1.87
4.63
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2522
23542
1.12
4.62
4.3
4.1
estimate
0.0
0.0
1.34
553
4180
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
431
3504
1.25
4.50
1.8
1.7
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
14
39
3.60
4.48
1.2
1.5
%
22.9
14.6
—
7
23
(3021901) Oxygen saturation in Capillary blood
155
1089
1.43
4.43
2.7
2.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
234
1769
1.34
4.31
5.7
3.9
mmol/l
3.8
3.9
2.86
219
1651
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
24
95
2.53
4.29
3.1
3.4
u/l
68.7
41.0
—
7
30
(3021601) Nitrite [Presence] in Urine by Test strip
2480
23241
1.12
4.08
5.8
5.4
estimate
0.0
0.0
0.41
557
4291
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
49
269
1.83
3.89
2.8
3.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
632
5427
1.18
3.81
1.4
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
49
3.07
3.80
1.1
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
86
555
1.56
3.77
2.7
3.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
48
266
1.81
3.72
1.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
48
266
1.81
3.72
1.5
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
48
266
1.81
3.72
1.5
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
48
266
1.81
3.72
1.5
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
408
3374
1.22
3.68
4.0
3.6
mmol/l
1.7
1.9
0.43
291
2468
(3043410) Blood group antigens tested for on Red Blood Cells
31
148
2.10
3.67
2.2
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2466
23223
1.11
3.54
4.2
4.0
estimate
0.0
0.0
0.50
548
4272
(3009343) pH of Capillary blood
420
3499
1.22
3.54
4.1
3.7
ph
7.4
7.4
0.12
54
435
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4085
42184
0.90
3.53
3.9
4.2
mmol/l
1.3
1.3
5.32
3605
37468
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
194
2524
0.76
3.47
1.3
1.3
au/ml
44.5
57.6
0.41
13
110
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
39
208
1.88
3.43
1.5
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
39
208
1.88
3.43
1.5
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
169
1264
1.35
3.42
1.3
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
424
3549
1.21
3.41
4.1
3.7
kpa
5.0
5.2
2.37
397
3235
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
75
482
1.56
3.38
1.7
2.1
u/field
3.4
1.8
1.00
28
169
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
39
210
1.86
3.34
1.5
1.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
15
364
0.41
3.17
1.0
1.0
ng/l
46.0
45.2
—
8
232
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
15
364
0.41
3.17
1.0
1.0
ng/l
682.1
681.2
—
8
228
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
161
1211
1.34
3.16
1.3
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
222
2800
0.78
3.15
2.4
2.4
au/ml
23.7
26.4
—
9
95
(4034850)
114
1579
0.72
3.13
14.9
11.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
15
362
0.41
3.13
1.0
1.0
ng/l
261.8
327.6
—
8
234
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
57
350
1.63
3.13
1.3
1.8
u/l
338.3
1314.3
0.64
12
126
(3024891) Influenza virus A+B Ag [Presence] in Specimen
148
1105
1.35
3.07
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
99
1398
0.70
3.06
1.4
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
55
338
1.63
3.02
3.3
2.4
ph
7.4
7.4
0.87
18
125
(3006270) Folate [Moles/volume] in Blood
75
500
1.51
2.92
1.3
1.2
nmol/l
309.4
331.4
0.38
57
394
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
7
13
5.39
2.86
2.0
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
34
186
1.83
2.82
1.1
1.3
ug/l
1150.3
306.6
0.55
18
91
(3048689) Calprotectin [Mass/mass] in Stool
525
4559
1.17
2.81
1.9
2.1
ug/g
256.1
161.1
4.12
404
3520
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4347
44579
0.91
2.79
4.9
5.1
mmol/l
6.2
6.1
3.81
3870
39674
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
72
1050
0.68
2.70
1.5
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
337
2829
1.20
2.69
5.2
3.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
147
1122
1.32
2.67
2.0
2.9
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
15
61
2.46
2.61
1.3
1.3
ug/l
41.6
131.6
—
8
37
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
34
191
1.78
2.61
2.8
2.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1203
13045
0.90
2.60
3.1
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3288
34092
0.92
2.60
3.7
3.9
pmol/l
15.0
15.1
0.26
2886
30273
(40768795) Lymph node Pathology biopsy report
68
457
1.49
2.59
1.1
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
75
516
1.46
2.55
1.1
1.2
u/l
91.9
60.0
0.97
47
342
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
357
4189
0.84
2.55
1.6
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
72
493
1.47
2.51
1.8
1.9
—
1.0
—
0
22
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
60
892
0.67
2.51
1.4
1.4
e6/l
238.3
963.9
2.18
51
735
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
60
892
0.67
2.51
1.4
1.4
e6/l
26.5
23.7
0.06
51
694
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
176
2210
0.79
2.47
1.8
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
72
495
1.46
2.47
1.3
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
23
116
1.99
2.45
1.3
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
133
1016
1.32
2.43
1.4
1.3
mmol/l
51.5
62.9
3.28
92
820
(3007164) IgA [Mass/volume] in Serum or Plasma
829
7502
1.12
2.43
1.5
1.5
g/l
2.7
2.6
0.22
465
4298
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
188
1503
1.26
2.42
1.6
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
118
1554
0.75
2.41
1.1
1.2
u/ml
0.2
1.0
—
9
148
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
159
0.31
2.40
1.0
1.9
ug/l
28.9
67.9
—
5
147
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
123
933
1.33
2.37
1.3
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
161
1268
1.28
2.35
2.0
2.3
g/l
121.6
126.9
1.66
119
918
(3037522) Nuclear Ab [Titer] in Serum
481
5473
0.87
2.33
1.3
1.3
titre
547.9
518.2
0.12
109
1190
(3008898) HLA-B27 [Presence]
68
970
0.70
2.31
1.1
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
28
3.22
2.30
1.2
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
29
162
1.79
2.30
2.6
1.4
umol/l
27.4
29.6
0.52
29
156
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
75
528
1.43
2.29
1.3
1.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
36
215
1.68
2.28
1.8
4.3
mg/l
65.0
65.7
0.02
22
150
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
48
309
1.56
2.26
1.5
1.6
u/l
2.5
6.7
2.04
21
143
(3014271) Vancomycin [Susceptibility]
55
366
1.51
2.24
2.9
3.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
274
3234
0.84
2.13
2.1
2.1
nmol/l
10.0
12.0
3.84
239
2781
(3045683) HLA typing for celiac disease panel - Blood or Tissue
30
174
1.73
2.12
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
295
2508
1.19
2.11
4.5
3.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
25
138
1.81
2.08
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
176
1425
1.24
2.08
3.1
3.1
nmol/l
0.9
0.8
0.35
137
1082
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1874
17780
1.08
2.00
4.7
4.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
80
1079
0.74
1.98
1.4
1.7
mg/l
3.6
3.7
0.03
64
773
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1521
16133
0.92
1.98
2.1
2.2
u/l
253.4
216.5
0.63
1435
14998
(3045424) Erythrocytes [Presence] in Urine
106
814
1.31
1.94
1.8
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
34
210
1.62
1.94
1.4
1.5
%
4.3
2.5
0.33
27
172
(3019150) Specific gravity of Urine by Refractometry
977
10551
0.91
1.93
4.5
4.6
kg/l
1.0
1.0
0.29
180
1662
(3012441) Differential panel - Pleural fluid
92
693
1.33
1.92
1.4
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1373
12886
1.09
1.92
4.5
4.5
estimate
0.0
0.0
0.27
508
4071
(3015235) Bicarbonate [Moles/volume] in Capillary blood
182
1494
1.23
1.92
2.8
3.1
mmol/l
24.0
25.0
2.14
161
1285
(3019832) Treponema pallidum Ab [Presence] in Serum
113
1442
0.78
1.89
1.4
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
40
259
1.55
1.89
1.3
1.5
%
56.7
67.0
0.99
32
207
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
64
458
1.40
1.85
1.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
64
458
1.40
1.85
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
64
458
1.40
1.85
1.4
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
111
868
1.28
1.79
3.9
4.8
iu/ml
372.7
3342.4
0.84
13
130
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
104
807
1.29
1.79
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
112
878
1.28
1.78
2.7
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
436
3874
1.14
1.78
1.4
1.7
%
1.5
1.6
0.13
369
3266
(3038177) Helicobacter pylori Ab [Presence] in Serum
76
564
1.35
1.78
1.3
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
235
1994
1.19
1.77
2.3
2.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
80
599
1.34
1.77
2.6
4.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
169
1.66
1.76
4.2
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
169
1.66
1.76
4.2
2.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
77
575
1.34
1.74
2.7
3.7
%
60.9
58.0
0.41
43
347
(1002224) Polysomnography panel
95
1223
0.77
1.73
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
125
998
1.26
1.72
1.1
1.1
u/ml
7.7
8.7
0.07
11
74
(21494755) Public health laboratory ask at order entry panel
151
1839
0.82
1.70
1.3
1.4
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
48
0.00
1.69
0.0
1.9
—
1.3
—
0
26
(4027681)
8
177
0.45
1.69
1.4
1.2
—
—
—
0
0
(4010399)
304
3478
0.87
1.66
1.4
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
19
3.16
1.66
3.8
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
19
3.16
1.66
7.7
6.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
69
2.03
1.64
1.7
1.9
—
—
—
0
0
(4094501)
99
1253
0.79
1.60
1.1
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
43
295
1.46
1.59
1.4
1.4
umol/l
14.9
14.2
0.16
38
276
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
32
206
1.56
1.59
1.6
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
363
0.60
1.58
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
73
551
1.33
1.56
1.5
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
31
471
0.66
1.56
1.2
1.2
mmol/l
7.4
7.8
0.32
25
335
(3049717) Cytology report of Urine Cyto stain
280
2439
1.16
1.56
2.9
2.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
347
3069
1.14
1.55
3.8
3.3
e9/l
3.9
4.2
1.07
250
2204
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
57
2.11
1.54
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
130
1058
1.23
1.54
1.6
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
192
2259
0.84
1.52
1.2
1.3
u/ml
213.5
213.7
0.00
174
2050
(3035880) pH of Pleural fluid
51
366
1.40
1.50
1.2
1.3
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
21
2.86
1.50
1.0
1.1
nmol/l
190.0
283.5
—
6
21
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
45
0.00
1.49
0.0
2.0
—
18.6
—
0
45
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
38
259
1.47
1.47
1.1
1.1
u/l
89.6
89.8
0.01
32
193
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
38
259
1.47
1.47
1.1
1.1
u/l
38.7
33.9
0.15
31
190
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
246
2134
1.16
1.46
5.0
4.1
mmol/l
24.6
24.8
0.30
222
1928
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
280
0.57
1.46
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
280
0.57
1.46
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
280
0.57
1.46
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
18
305
0.59
1.46
1.2
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
305
0.59
1.46
1.2
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
6
22
2.73
1.43
1.8
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
278
0.57
1.43
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
50
682
0.73
1.42
1.4
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
277
0.58
1.41
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
277
0.58
1.41
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
226
0.53
1.41
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
112
908
1.24
1.41
1.3
1.5
g/l
30.8
30.9
0.04
103
808
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2039
19602
1.06
1.40
2.2
2.2
nmol/l
76.4
79.3
4.67
1825
17080
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
34
230
1.48
1.38
1.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
77
598
1.29
1.38
1.3
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
102
1259
0.81
1.37
1.3
1.5
g/l
1.2
1.2
0.06
96
1184
(3003327) Ova and parasites identified in Stool by Light microscopy
142
1185
1.20
1.36
1.7
1.7
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
40
281
1.43
1.35
1.8
1.8
u/field
2.4
2.1
0.13
30
194
(3006462) Nitrate [Presence] in Urine
35
240
1.46
1.34
4.5
3.8
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
20
120
1.67
1.33
1.2
1.4
g/l
30.6
27.2
0.51
15
95
(3047189) Immunofixation for 24 hour Urine
18
297
0.60
1.33
1.4
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
44
605
0.73
1.33
3.7
4.4
umol/l
336.8
343.4
0.12
36
513
(3023199) Leukocytes [#/volume] in Pleural fluid
99
798
1.24
1.32
1.4
1.5
e6/l
1117.8
1743.0
2.23
80
580
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4074
41481
0.94
1.32
4.5
4.8
mu/l
2.8
2.1
0.59
3584
37039
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
56
420
1.34
1.30
1.0
1.1
u/ml
6.8
2.4
0.44
21
139
(3019230) Fractional oxyhemoglobin in Venous blood
109
892
1.23
1.28
1.9
2.6
%
62.1
62.0
0.02
109
887
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
47
344
1.37
1.27
1.2
1.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
6
133
0.45
1.27
1.0
1.2
—
25.1
—
0
17
(3021879) Hepatitis B virus core Ab [Presence] in Serum
267
2358
1.14
1.27
1.2
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
58
439
1.32
1.27
2.0
2.2
ml
761.8
638.5
0.70
29
265
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
63
1.91
1.22
2.1
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
24
156
1.54
1.19
2.2
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
89
719
1.24
1.19
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
57
739
0.77
1.19
1.8
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
35
247
1.42
1.18
6.3
6.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
101
1225
0.82
1.18
1.3
1.5
g/l
0.2
0.2
0.18
96
1154
(3044290) Cell count panel - Cerebral spinal fluid
64
816
0.78
1.17
1.3
1.3
—
—
—
0
0
(44813793)
14
237
0.59
1.17
1.1
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
29
417
0.69
1.17
1.4
1.6
—
1146.7
—
0
12
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
79
1.77
1.16
1.1
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
39
2.05
1.15
1.4
1.9
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
260
0.61
1.15
1.2
1.7
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
39
283
1.38
1.14
1.1
1.2
u/l
57.5
25.4
0.97
32
237
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
113
0.44
1.12
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
84
681
1.24
1.11
1.4
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
51
1.96
1.11
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
89
727
1.23
1.10
1.4
1.5
e6/l
194078.9
66696.6
0.81
59
433
(36660697) Celiac disease serology panel - Serum
334
3025
1.11
1.08
1.2
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
25
363
0.69
1.08
1.7
2.2
mmol/l
8.4
6.9
0.92
18
244
(3032057) Clostridioides difficile [Presence] in Stool
21
136
1.55
1.08
1.7
1.9
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
40
295
1.36
1.07
1.1
1.2
u/l
254.8
93.7
0.79
33
253
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
59
1.87
1.07
2.7
2.7
u/field
1.0
0.4
0.75
11
59
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
58
453
1.28
1.06
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
349
0.69
1.05
1.5
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
465
0.73
1.05
1.4
1.6
—
—
—
0
0
(4211845)
36
262
1.38
1.05
4.4
3.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
198
2243
0.88
1.03
1.1
1.2
iu/ml
117.7
130.4
0.19
56
777
(21494814) CD8 cells/100 lymphocytes in Specimen
25
171
1.46
1.02
2.1
2.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
34
247
1.38
1.01
2.0
2.4
ml
1703.2
1831.7
0.35
34
204
(3000034) Microalbumin [Mass/volume] in Urine
64
510
1.26
1.00
3.3
3.0
mg/l
62.2
34.2
0.33
48
381
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
188
0.58
0.98
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
47
606
0.77
0.98
1.1
1.3
miu/ml
98.1
212.5
3.36
16
219
(3036782) Glucose [Moles/volume] in Pleural fluid
74
602
1.23
0.98
1.3
1.4
mmol/l
6.6
6.4
0.15
69
555
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
445
4810
0.92
0.97
1.3
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
248
0.64
0.97
1.2
1.6
g/l
0.8
0.9
0.71
16
248
(3004451) EKG impression Narrative
40
301
1.33
0.96
1.3
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
31
224
1.39
0.96
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
31
224
1.39
0.96
1.1
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
14
223
0.63
0.96
1.1
1.3
mmol/l
6.2
6.1
0.10
14
211
(3036481) Cortisol [Moles/volume] in Serum or Plasma
438
4051
1.09
0.94
2.6
2.2
nmol/l
398.1
374.4
1.54
408
3677
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
38
285
1.34
0.94
1.2
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
38
285
1.34
0.94
1.2
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
68
834
0.81
0.94
1.5
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
27
2.22
0.93
1.8
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
16
101
1.59
0.93
1.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
28
200
1.40
0.93
2.0
2.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
569
5323
1.08
0.93
2.3
2.4
ug/l
4.8
6.9
2.71
475
4526
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
183
0.60
0.90
1.1
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
104
0.48
0.88
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1068
11155
0.95
0.87
3.2
3.3
ug/l
0.8
0.8
0.04
754
7988
(3000492) Spirometry study
349
3788
0.92
0.86
1.4
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
86
722
1.19
0.86
2.1
2.1
mg/l
32.1
25.1
0.42
23
175
(3027008) Opiates [Presence] in Urine
35
459
0.76
0.86
1.3
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
35
458
0.76
0.85
1.3
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
42
326
1.29
0.84
1.2
1.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
35
457
0.76
0.83
1.6
1.8
—
3.6
—
0
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
57
461
1.24
0.83
1.3
1.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
24
171
1.41
0.82
2.3
2.5
—
33.2
—
0
5
(3006576) Bicarbonate [Moles/volume] in Blood
26
188
1.38
0.82
4.6
6.9
mmol/l
24.9
24.6
0.05
21
169
(3011648) Oxygen content in Venous blood
49
390
1.26
0.82
1.6
2.0
%
11.4
10.7
0.45
49
390
(40761535) Cells panel - Urine sediment
422
4526
0.93
0.80
3.8
3.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
112
1290
0.87
0.80
1.7
1.6
e6/l
17930.6
14987.4
0.30
85
915
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
66
1.67
0.78
1.1
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
31
406
0.76
0.77
1.1
1.1
—
2.9
—
0
8
(3006922) Hepatitis E virus Ab [Presence] in Serum
32
243
1.32
0.76
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
210
0.67
0.76
1.5
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
162
0.62
0.76
1.1
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1527
15761
0.96
0.76
4.4
4.7
%
22.5
22.1
0.40
818
8342
(3035320) C reactive protein [Mass/volume] in Body fluid
44
350
1.26
0.75
2.3
2.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
102
884
1.16
0.73
1.4
1.4
nmol/l
0.8
0.8
0.04
89
723
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
133
1.43
0.73
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
634
6681
0.94
0.73
11.8
8.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
51
623
0.82
0.73
1.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
43
343
1.26
0.73
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
6
107
0.56
0.72
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
109
1246
0.87
0.72
1.6
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
230
0.69
0.72
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1720
16727
1.04
0.70
4.1
4.0
mg/mmol
10.8
9.5
0.45
1132
10541
(21494815) CD4 cells/100 lymphocytes in Specimen
41
327
1.26
0.70
1.8
2.0
%
31.5
40.6
—
6
35
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
217
0.69
0.70
1.3
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
57
472
1.21
0.70
1.2
1.3
u/l
14.4
12.0
0.29
51
427
(4133840)
14
93
1.51
0.69
1.2
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
251
0.72
0.69
2.1
2.5
%
36.6
36.6
—
5
97
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
139
1238
1.13
0.68
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
53
437
1.21
0.68
1.1
1.1
u/ml
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
330
0.76
0.68
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
72
612
1.18
0.67
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
36
452
0.80
0.67
1.3
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
135
1513
0.89
0.67
1.6
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
75
640
1.17
0.67
1.4
1.3
nmol/l
0.6
0.7
1.15
69
608
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
43
1.63
0.66
1.3
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
43
348
1.24
0.66
1.0
1.2
—
—
—
0
0
(44806118)
65
549
1.19
0.66
1.2
1.4
—
—
—
0
0
(44790047)
65
549
1.19
0.66
1.2
1.4
—
—
—
0
0
(44790048)
65
549
1.19
0.66
1.2
1.4
—
—
—
0
0
(44790049)
65
549
1.19
0.66
1.2
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1626
15818
1.04
0.65
3.3
3.2
mg/l
268.0
333.9
0.33
1093
10040
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
76
884
0.86
0.65
1.2
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
69
587
1.18
0.65
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
72
615
1.17
0.64
1.3
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
12
178
0.67
0.64
1.1
1.1
—
485.3
—
0
49
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
29
224
1.30
0.64
1.1
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
11
166
0.66
0.64
1.4
1.2
g/l
—
0.2
—
0
12
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
189
0.69
0.63
1.2
1.4
ug/l
4.5
8.4
3.13
13
165
(3016879) Cocaine [Presence] in Urine
34
426
0.80
0.63
1.4
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
39
314
1.24
0.63
1.9
1.9
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
16
112
1.43
0.63
1.4
1.5
%
8.0
5.8
—
8
53
(3022689) Creatine [Moles/volume] in Urine
8
131
0.61
0.63
1.5
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
16
223
0.72
0.62
1.3
1.4
pmol/l
103.5
182.6
—
5
74
(3024932) HLA-DR beta [Type]
6
103
0.58
0.62
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
211
0.71
0.62
1.3
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
142
1576
0.90
0.61
2.7
2.3
g/l
0.0
0.0
0.00
131
1436
(3037556) Urate [Mass/volume] in Serum or Plasma
11
164
0.67
0.61
1.1
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
66
564
1.17
0.60
1.4
1.3
nmol/l
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
163
0.67
0.59
1.3
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
8
52
1.54
0.59
3.1
2.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
48
399
1.20
0.59
1.3
1.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
8
53
1.51
0.58
7.6
4.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
30
238
1.26
0.56
1.0
1.1
u/ml
6.1
2.2
—
9
91
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
85
746
1.14
0.56
1.3
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
78
891
0.87
0.55
1.2
1.2
—
6.3
—
0
9
(3009871) Measles virus Ab [Titer] in Serum
5
90
0.56
0.55
1.4
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
123
1364
0.90
0.54
1.6
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
38
1.58
0.54
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
74
645
1.15
0.54
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
74
645
1.15
0.54
1.2
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
60
1.50
0.54
1.7
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
27
213
1.27
0.53
1.0
1.2
nmol/l
120.1
135.7
0.95
27
213
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
134
1214
1.11
0.53
3.2
2.7
mg/l
1.9
1.7
0.98
118
1082
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
170
0.71
0.53
2.0
2.1
umol/l
142.7
127.1
—
6
100
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
31
382
0.81
0.52
1.1
1.1
—
27.8
—
0
7
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
36
295
1.22
0.52
2.5
2.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
16
117
1.37
0.52
1.1
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
98
0.61
0.52
1.8
4.6
—
—
—
0
0
(4268621)
43
360
1.20
0.51
2.2
2.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
136
0.66
0.51
1.7
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
157
0.70
0.51
1.9
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
37
306
1.21
0.50
2.2
2.0
min
500.3
490.8
0.24
22
210
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
652
6267
1.05
0.49
4.3
4.8
%
32.9
33.3
0.38
418
4034
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
17
127
1.34
0.49
1.5
1.4
—
1742191.7
—
0
6
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
28
225
1.25
0.49
1.3
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
167
0.72
0.49
1.3
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
41
344
1.19
0.48
5.6
4.8
u/ml
42.5
68.1
0.52
11
98
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
278
0.79
0.47
1.6
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
148
1358
1.09
0.47
2.2
2.3
ug/min
115.6
100.4
0.15
79
787
(3011412) CD3 cells [#/volume] in Blood
47
401
1.17
0.47
2.1
2.0
e9/l
1.3
1.1
0.20
29
248
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
68
1.47
0.47
1.1
1.2
—
—
—
0
0
(3036603) Volume of Urine
40
337
1.19
0.46
1.5
1.7
ml
1826.2
1836.3
0.02
15
92
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
81
721
1.13
0.46
1.3
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
120
1.33
0.46
2.2
2.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
94
1.38
0.45
1.6
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
118
0.68
0.45
1.3
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
118
0.68
0.45
1.1
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
45
384
1.17
0.45
1.1
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
85
0.59
0.45
1.4
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1648
16142
1.03
0.45
3.3
3.1
mmol/l
7.4
7.2
1.72
1355
13261
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
100
903
1.11
0.45
1.2
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
50
1.40
0.45
1.4
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
35
417
0.84
0.45
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
178
1916
0.93
0.44
1.2
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
19
242
0.78
0.44
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
17
130
1.31
0.43
4.8
7.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
119
1301
0.91
0.43
1.2
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
31
1.61
0.43
2.8
3.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
151
0.73
0.42
1.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
89
803
1.11
0.41
2.2
2.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
82
911
0.90
0.41
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
15
0.00
0.41
0.0
1.1
—
8.3
—
0
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
94
1036
0.91
0.41
1.1
1.2
u/ml
2.6
6.4
1.91
19
171
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
16.6
—
0
5
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
5.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
3.2
—
0
17
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
60
1.33
0.40
2.3
1.4
umol/l
43.0
44.6
—
8
60
(3048879) Bone marrow aspiration report
21
168
1.25
0.40
1.6
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
93
1023
0.91
0.39
1.1
1.2
u/ml
5.7
3.3
0.46
13
100
(3016650) Hepatitis A virus Ab [Presence] in Serum
68
607
1.12
0.39
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
43
372
1.16
0.38
1.4
1.5
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
16
124
1.29
0.38
1.3
1.2
nmol/l
94.7
126.8
0.76
11
93
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
20
160
1.25
0.38
2.0
2.0
u/l
19.0
52.0
1.32
20
148
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
67
1.34
0.38
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
101
1103
0.91
0.38
1.1
1.2
u/ml
50.0
42.2
—
5
59
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
55
621
0.88
0.37
1.2
1.2
u/ml
352.4
293.8
0.50
32
380
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
44
384
1.15
0.36
1.1
1.2
%
98.6
94.0
0.70
39
354
(40760888) Immunoglobulin light chains.free panel - Serum
140
1503
0.93
0.36
2.6
3.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
183
1946
0.94
0.36
2.8
3.2
ratio
1.5
3.5
1.34
11
146
(3034860) Kappa light chains.free [Mass/volume] in Serum
188
1997
0.94
0.35
2.8
3.2
mg/l
96.6
86.4
0.09
158
1636
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
157
0.76
0.35
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
78
0.64
0.35
1.2
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
150
1605
0.93
0.35
2.6
2.3
g/l
0.0
0.0
0.65
132
1443
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
188
1994
0.94
0.34
2.8
3.2
mg/l
43.4
56.4
0.86
158
1634
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
89
814
1.09
0.34
1.3
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
507
4901
1.04
0.33
2.4
2.6
g/l
65.2
66.0
1.23
451
4368
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
10
133
0.75
0.33
1.3
1.9
%
31.4
29.4
—
10
121
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
79
720
1.10
0.33
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
228
1.19
0.33
1.0
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
315
3289
0.96
0.33
2.6
2.7
g/l
10.6
10.6
0.00
283
2976
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
22
264
0.83
0.33
1.5
1.5
nmol/l
0.2
0.2
0.03
13
198
(3023410) Appearance of Cerebral spinal fluid
32
371
0.86
0.33
1.5
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1297
13216
0.98
0.32
2.9
2.8
umol/l
4109.9
5890.8
0.90
1123
11123
(3017569) Oxygen content in Arterial blood
35
303
1.16
0.32
2.1
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
70
635
1.10
0.32
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
74
1.35
0.32
1.2
1.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
15
187
0.80
0.32
1.1
1.2
g/l
35.5
40.0
—
7
89
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
13
101
1.29
0.31
1.0
1.3
%
91.3
81.9
—
7
57
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
187
1976
0.94
0.31
2.5
2.4
g/l
1.0
1.1
0.03
156
1660
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
11
142
0.77
0.30
7.0
12.2
mmol/l
0.8
0.6
0.57
11
134
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
59
533
1.11
0.30
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
115
1232
0.93
0.30
1.5
1.6
iu/ml
4.7
11.5
0.46
26
293
(3018133) Calcium [Moles/volume] in Urine
7
55
1.27
0.30
1.3
1.7
mmol/l
1.5
2.9
—
7
45
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
37
325
1.14
0.29
1.4
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
434
4199
1.04
0.29
3.7
3.7
ng/l
102.2
95.9
0.65
381
3518
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
188
1785
1.05
0.29
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
326
1.14
0.28
1.4
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
121
1.24
0.28
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
31
355
0.87
0.28
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
62
680
0.91
0.28
1.2
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
162
0.80
0.28
1.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
54
488
1.11
0.28
1.1
1.1
%
114.2
115.0
0.07
46
428
(3024263) Appearance of Synovial fluid
25
291
0.86
0.28
1.7
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
85
1.29
0.28
1.3
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
63
1.27
0.27
1.4
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
116
0.78
0.27
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
116
0.78
0.27
1.4
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
28
322
0.87
0.27
19.7
14.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
59
537
1.10
0.27
1.2
1.2
u/ml
1.9
4.9
4.02
29
235
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
34
299
1.14
0.27
2.1
2.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
121
0.74
0.27
1.7
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
131
1.22
0.27
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
87
937
0.93
0.27
1.6
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
103
962
1.07
0.27
1.2
1.3
—
—
—
0
0
(4146454)
68
624
1.09
0.27
2.5
2.7
—
—
—
0
0
(44806420)
23
196
1.17
0.27
2.4
2.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
268
0.86
0.26
1.3
1.3
u/ml
0.2
1.2
1.48
13
140
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
57
624
0.91
0.26
1.2
1.1
iu/ml
16529.8
65.8
0.47
11
118
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
181
0.83
0.25
1.2
1.1
ratio
1.1
1.1
—
5
55
(3024980) IgG subclass 4 [Mass/volume] in Serum
58
633
0.92
0.25
1.5
1.6
g/l
0.8
0.8
0.07
42
480
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
81
754
1.08
0.24
1.3
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
30
339
0.88
0.24
1.1
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
47
516
0.91
0.23
1.6
1.3
e6/l
60126.9
109286.3
0.57
34
361
(3003129) Base excess in Capillary blood by calculation
12
147
0.82
0.23
2.3
1.9
mmol/l
0.6
0.7
0.06
12
132
(3011985) Renin [Units/volume] in Plasma
58
630
0.92
0.23
1.3
1.4
mu/l
79.1
59.3
0.27
51
551
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
106
1.23
0.23
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
85
908
0.94
0.23
1.3
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
173
1808
0.96
0.22
2.5
2.2
g/l
36.7
37.2
0.49
140
1517
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
157
0.83
0.22
1.2
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
85
907
0.94
0.22
1.3
1.3
u/l
32.7
43.1
0.71
74
782
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
431
0.90
0.22
1.3
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
252
2611
0.96
0.22
2.0
1.9
g/l
1.5
1.4
0.18
226
2333
(3003338) MCHC [Mass/volume]
3647
36263
1.01
0.21
39.2
22.4
g/l
328.6
331.5
57.56
3617
35861
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
60
555
1.08
0.21
1.2
1.2
u/ml
4.3
3.5
0.12
27
174
(3033923) Metanephrine [Moles/time] in 24 hour Urine
13
107
1.22
0.21
1.1
1.1
umol/24h
0.7
0.7
—
6
50
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
4.7
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
10
0.00
0.21
0.0
6.1
—
49.5
—
0
10
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
226
2178
1.04
0.21
2.1
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
125
1315
0.95
0.21
1.7
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
109
1151
0.95
0.21
2.4
2.4
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
103
0.78
0.21
1.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
103
0.78
0.21
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
103
0.78
0.21
1.6
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
104
0.77
0.21
1.8
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
158
1651
0.96
0.21
1.1
1.1
titre
178.3
230.8
—
6
33
(3000093) Morphology [Interpretation] in Blood Narrative
49
533
0.92
0.21
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
74
791
0.93
0.21
1.3
1.3
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
13
0.00
0.21
0.0
5.0
—
371.6
—
0
13
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
89
1.24
0.20
1.3
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
165
1721
0.96
0.20
2.5
2.3
g/l
0.2
0.1
0.35
147
1553
(3017704) Immunofixation for Urine
31
345
0.90
0.20
1.6
1.5
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
6
48
1.25
0.20
6.5
4.9
ug/min
47.3
60.4
—
6
40
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
28
313
0.89
0.20
4.1
3.9
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
145
1387
1.05
0.19
1.5
1.4
iu/ml
7.2
18.0
—
6
29
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
99
1.21
0.19
1.0
1.1
%
91.2
83.3
—
6
54
(3005011) Chlamydia sp Ab [Titer] in Serum
6
51
1.18
0.19
1.7
1.8
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
24
270
0.89
0.19
1.2
1.1
nmol/l
3.7
12.4
—
9
63
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
174
1674
1.04
0.19
1.6
1.6
titre
76.0
255.6
—
5
82
(21494434) Karyotype in Bone marrow
53
492
1.08
0.18
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
346
3372
1.03
0.18
3.1
3.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
216
2233
0.97
0.18
1.3
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
442
4519
0.98
0.18
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
55
512
1.07
0.18
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
59
631
0.93
0.18
1.8
2.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
60
1.17
0.17
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
60
1.17
0.17
1.0
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
28
252
1.11
0.17
1.1
1.3
nmol/l
1.3
1.2
0.37
23
188
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
300
1.10
0.17
1.9
2.0
%
11.2
14.9
—
9
120
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
14
119
1.18
0.17
1.1
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
67
630
1.06
0.17
1.8
1.5
%
66.2
62.3
0.37
47
407
(4198724)
7
63
1.11
0.17
1.6
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
73
689
1.06
0.17
1.3
1.3
u/l
17.0
10.7
1.72
58
553
(3026389) Candida sp identified in Specimen by Organism specific culture
66
621
1.06
0.16
1.1
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
70
0.71
0.16
10.0
13.6
mmol/l
8.0
5.3
—
5
70
(3040151) Glucose [Moles/volume] in Capillary blood
71
670
1.06
0.16
9.6
17.9
mmol/l
7.2
7.5
0.39
62
545
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
82
864
0.95
0.16
1.1
1.2
u/ml
2.8
5.5
—
8
64
(40758047) Lysozyme [Mass/volume] in Pleural fluid
8
70
1.14
0.16
1.1
1.2
mg/l
13.6
7.2
—
8
64
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
72
1.11
0.16
2.6
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
464
4552
1.02
0.15
1.4
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
77
0.78
0.15
1.3
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
78
0.77
0.15
1.2
1.7
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
79
0.76
0.15
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
63
594
1.06
0.15
4.5
3.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
119
0.84
0.15
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
140
0.86
0.15
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
140
0.86
0.15
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
140
0.86
0.15
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
140
0.86
0.15
1.4
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
16
140
1.14
0.15
1.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
72
683
1.05
0.15
3.2
2.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
71
748
0.95
0.14
1.2
1.3
iu/l
35.3
33.8
0.12
55
633
(3051387) C reactive protein [Mass/volume] in Capillary blood
121
1164
1.04
0.14
3.8
3.8
mg/l
33.9
29.8
0.47
77
760
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
247
2407
1.03
0.14
3.0
3.2
pmol/l
4.2
4.4
1.25
212
2082
(3001186) Copper [Moles/volume] in Serum or Plasma
7
89
0.79
0.14
1.1
1.1
umol/l
17.0
16.1
—
7
80
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
93
1.18
0.14
1.0
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
191
1855
1.03
0.14
1.7
1.8
u/l
39.1
38.4
0.17
169
1580
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
118
0.85
0.14
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
118
1136
1.04
0.14
1.7
1.9
mg/l
11.8
12.4
0.27
109
1036
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
51
542
0.94
0.14
1.1
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
19
170
1.12
0.13
2.5
2.8
umol/l
31.8
29.5
—
10
122
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
16
180
0.89
0.13
3.1
2.1
umol/l
52.4
56.5
0.29
16
138
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
294
0.92
0.13
1.4
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
239
2333
1.03
0.13
2.3
2.3
g/l
7.7
7.5
1.38
174
1688
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
62
653
0.95
0.13
1.3
1.4
u/ml
117.7
122.0
0.14
13
142
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
132
1.14
0.13
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
18
161
1.12
0.13
1.1
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
32
297
1.08
0.12
1.1
1.3
promille
1.1
1.1
0.02
22
227
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
29
313
0.93
0.12
2.7
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
65
620
1.05
0.12
1.4
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
238
2328
1.02
0.12
2.3
2.3
g/l
3.8
3.8
0.26
163
1626
(3002523) Influenza virus A Ag [Presence] in Specimen
34
364
0.93
0.11
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
364
0.93
0.11
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
28
302
0.93
0.11
1.4
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
157
0.89
0.11
1.3
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
27
291
0.93
0.11
1.4
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
220
2153
1.02
0.11
2.4
2.4
g/l
3.2
3.1
1.01
167
1660
(3001019) Free T4 and TSH panel - Serum or Plasma
113
1095
1.03
0.10
1.6
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
238
2332
1.02
0.10
2.3
2.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
193
1.09
0.10
1.2
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
467
1.05
0.09
1.8
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
114
0.88
0.09
1.4
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
176
0.91
0.09
1.3
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
350
0.94
0.09
1.0
1.1
u/ml
1.7
1.1
0.17
11
142
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2246
22364
1.01
0.09
2.4
2.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
14
126
1.11
0.09
1.2
1.2
mmol/l
1.2
1.6
—
8
78
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
54
1.11
0.09
2.0
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
55
1.09
0.08
9.0
12.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
26
243
1.07
0.08
1.3
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
64
0.78
0.08
1.6
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
123
0.89
0.08
1.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
67
1.04
0.08
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1974
19662
1.01
0.07
5.1
5.4
ug/l
3.6
4.1
0.34
1721
17423
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
10
112
0.89
0.07
3.9
6.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
90
0.89
0.06
3.9
7.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
14
128
1.09
0.06
2.1
2.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
73
751
0.97
0.06
1.3
1.3
—
16.1
—
0
14
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
40
417
0.96
0.06
1.1
1.1
u/ml
0.6
1.9
1.69
11
163
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
102
0.88
0.06
2.8
3.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
103
0.87
0.06
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
26
246
1.06
0.06
1.3
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
109
1.10
0.06
1.6
1.5
ug/l
10.1
9.1
0.53
12
109
(3011397) Hemoglobin [Presence] in Urine by Test strip
1133
11385
0.99
0.06
3.7
4.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
29
276
1.05
0.06
2.0
1.9
e6/l
429.8
592.0
1.03
15
116
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
202
0.94
0.05
1.3
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
100
1.10
0.05
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
89
872
1.02
0.05
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
238
1.05
0.05
1.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
24
252
0.95
0.05
1.3
1.8
—
8.3
—
0
12
(4062490)
38
393
0.97
0.04
1.1
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
735
1.02
0.04
1.2
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
96
944
1.02
0.04
1.6
1.8
iu/l
7.4
4.8
0.50
25
295
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
111
1.08
0.04
4.5
7.7
—
—
—
0
0
(4024509)
57
557
1.02
0.03
1.7
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
129
0.93
0.03
1.0
1.1
miu/ml
1978.9
1641.1
0.37
12
129
(3042111) Morphology [Interpretation] in Bone marrow Narrative
99
1004
0.99
0.03
1.5
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
47
481
0.98
0.03
1.7
1.5
%
25.8
27.2
0.11
33
308
(3004588) Protein electrophoresis panel - Serum or Plasma
410
4121
0.99
0.03
2.3
2.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
11
118
0.93
0.02
1.1
1.1
u/ml
0.7
1.9
—
5
36
(40757494) Bilirubin.total [Moles/volume] in Blood
29
299
0.97
0.02
2.4
2.2
umol/l
21.2
32.6
—
5
29
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
262
1.03
0.02
1.0
1.0
u/ml
5.7
1.6
—
8
97
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
599
0.98
0.02
1.8
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
57
578
0.99
0.01
1.2
1.3
pmol/l
300.0
270.3
0.33
43
438
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
30
293
1.02
0.01
2.3
1.9
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
126
0.95
0.00
1.1
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
13
124
1.05
0.00
2.4
2.4
mmol/l
7.7
7.9
—
7
75
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
214
1.03
0.00
1.4
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
53
524
1.01
0.00
1.1
1.3
mosm/kgh2o
274.9
276.5
0.17
40
395
(40768793) Breast Pathology biopsy report
95
944
1.01
0.00
1.3
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
13
131
0.99
0.00
1.1
1.1
%
86.1
90.3
—
8
98
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
115
0.96
0.00
1.1
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
10
95
1.05
0.00
1.6
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
31
306
1.01
0.00
1.2
1.1
—
—
—
0
0
(4015189)
16
165
0.97
0.00
2.0
2.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
39
391
1.00
0.00
1.1
1.3
g/l
7.4
6.8
0.43
28
275
(3024139) IgG subclass 3 [Mass/volume] in Serum
39
391
1.00
0.00
1.1
1.3
g/l
0.5
0.4
0.57
28
276
(3028192) IgG subclass 2 [Mass/volume] in Serum
39
391
1.00
0.00
1.1
1.3
g/l
3.2
2.9
0.37
28
277
(4306422)
51
505
1.01
0.00
1.2
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
128
1.02
0.00
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
218
2183
1.00
0.00
2.3
2.3
g/l
10.1
10.3
0.16
181
1811
(3025577) Chromium [Mass/volume] in Blood
36
365
0.99
0.00
2.0
2.0
ug/l
2.0
2.1
0.08
31
311
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
30
299
1.00
0.00
1.1
1.2
mmol/l
11.6
12.2
0.15
12
91
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
360
1.00
0.00
1.0
1.0
u/ml
7.5
3.4
0.34
14
163
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
469
1.00
0.00
1.1
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
19
190
1.00
0.00
2.0
1.7
ug/l
63.3
53.8
0.51
19
184
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
188
1.01
0.00
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
23
234
0.98
0.00
1.7
1.4
%
0.8
3.8
—
6
57
(3009445) Proteinase 3 Ab [Units/volume] in Serum
217
2167
1.00
0.00
1.3
1.6
u/ml
26.3
19.8
—
5
58
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
208
1.01
0.00
1.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
97
1.03
0.00
1.2
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
97
1.03
0.00
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
297
2972
1.00
0.00
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
147
1.02
0.00
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
147
1.02
0.00
1.5
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
155
1555
1.00
0.00
1.1
1.1
u/ml
1.2
1.2
—
7
22
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
126
1.03
0.00
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
111
0.99
0.00
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
144
1445
1.00
0.00
1.5
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
111
0.99
0.00
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
111
0.99
0.00
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
111
0.99
0.00
1.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
27
265
1.02
0.00
3.0
2.2
mmol/l
9.9
9.3
0.38
17
205
(3047007) Chlamydophila sp Ab [Presence] in Serum
45
454
0.99
0.00
1.3
1.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
1468.8
—
0
8
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
7.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
98
0.92
0.00
1.2
1.6
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
115.2
—
0
7
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
98
0.92
0.00
1.4
1.5
ng/l
186.6
139.6
—
9
98
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
5
52
0.96
0.00
3.6
2.5
—
39.7
—
0
9
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
70
1.00
0.00
1.7
2.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
49
1.02
0.00
4.8
4.5
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
50
1.00
0.00
1.2
1.1
umol/24h
1.6
1.8
—
5
50
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(4212803)
6
60
1.00
0.00
1.2
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
71
0.99
0.00
1.7
2.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_COLON – Malignant neoplasm of colon
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).